148 related articles for article (PubMed ID: 36693714)
1. Papillomatous breast lesions with atypical columnar cell features.
de Boer M; Verschuur-Maes AHJ; Moelans C; van Diest PJ
J Clin Pathol; 2023 Apr; 76(4):228-233. PubMed ID: 36693714
[TBL] [Abstract][Full Text] [Related]
2. Dimorphic cells: a common feature throughout the low nuclear grade breast neoplasia spectrum.
de Boer M; van Diest PJ
Virchows Arch; 2023 Feb; 482(2):369-375. PubMed ID: 36378325
[TBL] [Abstract][Full Text] [Related]
3. Pathology of breast papillary neoplasms: Community hospital experience.
Vdovenko AA
Ann Diagn Pathol; 2020 Dec; 49():151605. PubMed ID: 32920473
[TBL] [Abstract][Full Text] [Related]
4. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
Martinez AP; Cohen C; Hanley KZ; Li XB
Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088
[TBL] [Abstract][Full Text] [Related]
5. Breast papillomas with atypical ductal hyperplasia: a clinicopathologic study.
Raju U; Vertes D
Hum Pathol; 1996 Nov; 27(11):1231-8. PubMed ID: 8912836
[TBL] [Abstract][Full Text] [Related]
6. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
[TBL] [Abstract][Full Text] [Related]
7. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
Niu F; Wang L; Zhang W; Lyu S; Niu Y
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593
[TBL] [Abstract][Full Text] [Related]
8. Central atypical papillomas of the breast: a clinicopathological study of 119 cases.
MacGrogan G; Tavassoli FA
Virchows Arch; 2003 Nov; 443(5):609-17. PubMed ID: 13680220
[TBL] [Abstract][Full Text] [Related]
9. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
[TBL] [Abstract][Full Text] [Related]
10. Papillary lesions of the breast: To excise or observe?
Khan S; Diaz A; Archer KJ; Lehman RR; Mullins T; Cardenosa G; Bear HD
Breast J; 2018 May; 24(3):350-355. PubMed ID: 28845569
[TBL] [Abstract][Full Text] [Related]
11. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.
Abdel-Fatah TM; Powe DG; Hodi Z; Lee AH; Reis-Filho JS; Ellis IO
Am J Surg Pathol; 2007 Mar; 31(3):417-26. PubMed ID: 17325484
[TBL] [Abstract][Full Text] [Related]
12. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy.
Irfan K; Brem RF
Breast J; 2002; 8(4):230-3. PubMed ID: 12100116
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia: an immunohistochemical study.
Umekita Y; Yoshida H
Pathol Int; 2000 Jul; 50(7):527-30. PubMed ID: 10886733
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
15. Pathological criteria and practical issues in papillary lesions of the breast - a review.
Ni YB; Tse GM
Histopathology; 2016 Jan; 68(1):22-32. PubMed ID: 26768027
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?
Tan PH; Aw MY; Yip G; Bay BH; Sii LH; Murugaya S; Tse GM
Am J Surg Pathol; 2005 May; 29(5):625-32. PubMed ID: 15832086
[TBL] [Abstract][Full Text] [Related]
17. Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
Gomes DS; Porto SS; Balabram D; Gobbi H
Diagn Pathol; 2014 Jun; 9():121. PubMed ID: 24948027
[TBL] [Abstract][Full Text] [Related]
18. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.
Simpson PT; Gale T; Reis-Filho JS; Jones C; Parry S; Sloane JP; Hanby A; Pinder SE; Lee AH; Humphreys S; Ellis IO; Lakhani SR
Am J Surg Pathol; 2005 Jun; 29(6):734-46. PubMed ID: 15897740
[TBL] [Abstract][Full Text] [Related]
19. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features.
Shiino S; Tsuda H; Yoshida M; Jimbo K; Asaga S; Hojo T; Kinoshita T
Pathol Int; 2015 Jun; 65(6):293-300. PubMed ID: 25801805
[TBL] [Abstract][Full Text] [Related]
20. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
Carder PJ; Garvican J; Haigh I; Liston JC
Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]